Trials / Withdrawn
WithdrawnNCT04395716
A Study of ResCure™ to Treat COVID-19 Infection
A Phase I Study of ResCure™ to Treat COVID-19 Infection
- Status
- Withdrawn
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- ProgenaBiome · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a Phase I open-label interventional study which will test the efficacy of ResCure™ in the treatment of patients with COVID-19 infection.
Detailed description
In this Phase I open-label interventional study we will test the efficacy of ResCure™ in the treatment of patients with COVID-19 infection. Patients being treated will have severe respiratory symptoms that are at or near requiring the patient be placed on a ventilator.
Conditions
- COVID
- Covid-19
- Corona Virus Infection
- Sars-CoV2
- Coronavirus-19
- SARS Pneumonia
- SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | ResCure™ | Patients will be treated with nebulized ResCure™ |
Timeline
- Start date
- 2020-01-01
- Primary completion
- 2021-06-01
- Completion
- 2021-11-01
- First posted
- 2020-05-20
- Last updated
- 2021-04-08
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04395716. Inclusion in this directory is not an endorsement.